PubRank

Richard C Semelka

Author PubWeight™ 93.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A 2008 2.73
2 Liver-vessel cancellation artifact on in-phase and out-of-phase MRI imaging: a sign of ultra-high liver fat content. J Magn Reson Imaging 2011 1.98
3 Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology 2008 1.84
4 Health effects of ionising radiation from diagnostic CT. Lancet 2006 1.61
5 Effect of antioxidants on X-ray-induced γ-H2AX foci in human blood lymphocytes: preliminary observations. Radiology 2012 1.59
6 Low quality and lack of clarity of current informed consent forms in cardiology: how to improve them. JACC Cardiovasc Imaging 2012 1.57
7 MRI findings of rapidly progressive hepatocellular carcinoma. Magn Reson Imaging 2010 1.45
8 MRI of acute abdominal and pelvic pain in pregnant patients. AJR Am J Roentgenol 2005 1.43
9 Health care systems of developed non-U.S. nations: strengths, weaknesses, and recommendations for the United States--observations from internationally recognized imaging specialists. AJR Am J Roentgenol 2011 1.42
10 Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab 2005 1.35
11 Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging 2003 1.24
12 Free-breathing 3D T1-weighted gradient-echo sequence with radial data sampling in abdominal MRI: preliminary observations. AJR Am J Roentgenol 2011 1.19
13 Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003 1.13
14 Inflammatory myofibroblastic tumor of the hepatobiliary system: report of MR imaging appearance in four patients. Radiology 2003 1.12
15 Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr 2010 1.10
16 Radiology's ethical responsibility for healthcare reform: tempering the overutilization of medical imaging and trimming down a heavyweight. J Magn Reson Imaging 2011 1.00
17 Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging 2003 0.99
18 Primary malignant mesothelioma of the liver: MR imaging findings. Magn Reson Imaging 2003 0.98
19 Undifferentiated (embryonal) sarcoma of the liver (USL): MRI findings including dynamic gadolinium enhancement. Magn Reson Imaging 2004 0.98
20 Accurate quantification of visceral adipose tissue (VAT) using water-saturation MRI and computer segmentation: preliminary results. J Magn Reson Imaging 2006 0.97
21 MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 2002 0.97
22 Emerging techniques: whole-body screening and staging with MRI. J Magn Reson Imaging 2006 0.96
23 Gadolinium- and superparamagnetic-iron-oxide-enhanced MR findings of intrapancreatic accessory spleen in five patients. Magn Reson Imaging 2008 0.96
24 Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases--a prospective randomized study in patients with chronic liver damage. Radiology 2002 0.95
25 MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging. Magn Reson Imaging 2009 0.94
26 Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertil Steril 2010 0.93
27 Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities. Radiology 2009 0.93
28 Modern hepatic imaging. Surg Clin North Am 2004 0.91
29 MR imaging of the pancreas. Magn Reson Imaging Clin N Am 2005 0.91
30 Acute cholecystitis: MR findings and differentiation from chronic cholecystitis. Radiology 2007 0.91
31 Free breathing three-dimensional gradient echo-sequence with radial data sampling (radial 3D-GRE) examination of the pancreas: Comparison with standard 3D-GRE volumetric interpolated breathhold examination (VIBE). J Magn Reson Imaging 2013 0.90
32 Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas: observation with MR imaging. Magn Reson Imaging 2010 0.90
33 Hepatocellular adenomas in men: MRI findings in four patients. J Magn Reson Imaging 2005 0.88
34 Magnetic resonance imaging of adenocarcinoma of the pancreas. Top Magn Reson Imaging 2009 0.88
35 MRI findings of primary small-cell carcinoma of kidney. Magn Reson Imaging 2005 0.88
36 Adult celiac disease: what is the role of MRI? J Magn Reson Imaging 2006 0.87
37 When should abdominal magnetic resonance imaging be used? Clin Gastroenterol Hepatol 2008 0.87
38 Giant hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging 2003 0.87
39 Contrast agents for MR imaging of the liver. Radiol Clin North Am 2005 0.85
40 Hepatic imaging: comparison of modalities. Radiol Clin North Am 2005 0.85
41 Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates. Liver Transpl 2006 0.85
42 Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients. J Magn Reson Imaging 2009 0.85
43 Magnetic resonance imaging of gallbladder and biliary system. Top Magn Reson Imaging 2009 0.85
44 A novel tool for user-friendly estimation of natural, diagnostic and professional radiation risk: Radio-Risk software. Eur J Radiol 2011 0.84
45 Imaging the pregnant patient with abdominal pain. Abdom Imaging 2012 0.84
46 Induction and repair of DNA double-strand breaks in blood lymphocytes of patients undergoing ¹⁸F-FDG PET/CT examinations. Eur J Nucl Med Mol Imaging 2012 0.84
47 Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. AJR Am J Roentgenol 2010 0.83
48 Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics. J Magn Reson Imaging 2003 0.83
49 Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques. J Magn Reson Imaging 2003 0.82
50 Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. J Magn Reson Imaging 2002 0.82
51 In-phase and out-of-phase gradient-echo imaging in abdominal studies: intra-individual comparison of three different techniques. Acta Radiol 2012 0.82
52 Accuracy of MRI skeletal age estimation for subjects 12-19. Potential use for subjects of unknown age. Int J Legal Med 2015 0.81
53 Suspected pancreatic cancer: evaluation by dynamic gadolinium-enhanced 3D gradient-echo MRI. AJR Am J Roentgenol 2005 0.81
54 Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. J Magn Reson Imaging 2012 0.81
55 Abdominal imaging studies: comparison of diagnostic accuracies resulting from ultrasound, computed tomography, and magnetic resonance imaging in the same individual. Magn Reson Imaging 2004 0.81
56 Early contrast enhancement of the liver: exact description of subphases using MRI. Magn Reson Imaging 2009 0.81
57 MR imaging of hepatic metastases. Magn Reson Imaging Clin N Am 2002 0.80
58 Comparison of T1-weighted in- and out-of-phase single shot magnetization-prepared gradient-recalled-echo with three-dimensional gradient-recalled-echo at 3.0 Tesla: preliminary observations in abdominal studies. J Magn Reson Imaging 2011 0.80
59 Magnetic resonance imaging of the gastrointestinal tract. Top Magn Reson Imaging 2005 0.80
60 Characterization of adrenal lesions with 1.5-T MRI: preliminary observations on comparison of three in-phase and out-of-phase gradient-echo techniques. AJR Am J Roentgenol 2011 0.80
61 Combined hepatocellular carcinoma-cholangiocarcinoma: report of MR appearance in eleven patients. J Magn Reson Imaging 2012 0.80
62 Debriefing the Brief: It is Time for the Provision of Informed Consent before Pediatric CT. Radiology 2015 0.80
63 Future horizons in MR imaging. Magn Reson Imaging Clin N Am 2005 0.80
64 MRI findings of recurrent hepatocellular carcinoma after liver transplantation: preliminary results. J Magn Reson Imaging 2011 0.80
65 Imaging the fatty liver. Magn Reson Imaging Clin N Am 2002 0.80
66 MR imaging of benign hepatic tumors. Magn Reson Imaging Clin N Am 2002 0.80
67 Magnetic resonance imaging of the liver: review of techniques and approach to common diseases. Semin Ultrasound CT MR 2005 0.80
68 3.0-T MRI evaluation of patients with chronic liver diseases: initial observations. Magn Reson Imaging 2008 0.80
69 Hepatic tumor response evaluation by MRI. NMR Biomed 2010 0.80
70 Value of MRI of the hand and the wrist in evaluation of bone age: preliminary results. J Magn Reson Imaging 2014 0.80
71 Enhancement of abdominal organs on hepatic arterial phase: quantitative comparison between 1.5- and 3.0-T magnetic resonance imaging. Magn Reson Imaging 2009 0.80
72 Comparison of a single shot T1-weighted in- and out-of-phase magnetization prepared gradient recalled echo with a standard two-dimensional gradient recalled echo: preliminary findings. J Magn Reson Imaging 2011 0.79
73 Evaluation of radiologist interpretive performance using blinded reads by multiple external readers. Invest Radiol 2010 0.79
74 Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging 2009 0.79
75 Quarter-dose (0.025 mmol/kg) gadobenate dimeglumine for abdominal MRI in patients at risk for nephrogenic systemic fibrosis: preliminary observations. AJR Am J Roentgenol 2011 0.79
76 Nephrogenic systemic fibrosis and management of high-risk patients. Acad Radiol 2009 0.79
77 Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms. Top Magn Reson Imaging 2009 0.79
78 Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 2007 0.79
79 The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI. Am J Gastroenterol 2006 0.79
80 Pre-, peri-, and posttreatment imaging of liver lesions. Radiol Clin North Am 2005 0.78
81 Water excitation MPRAGE: an alternative sequence for postcontrast imaging of the abdomen in noncooperative patients at 1.5 Tesla and 3.0 Tesla MRI. J Magn Reson Imaging 2008 0.78
82 Whole-body magnetic resonance imaging. Top Magn Reson Imaging 2005 0.78
83 MR cholangiopancreatography. Radiol Clin North Am 2003 0.78
84 Liver masses. Magn Reson Imaging Clin N Am 2005 0.78
85 Combined chemical shift imaging with early dynamic serial gadolinium-enhanced MRI in the characterization of adrenal lesions. AJR Am J Roentgenol 2014 0.78
86 MR imaging of diffuse liver disease. Radiol Clin North Am 2003 0.78
87 MR imaging findings in autoimmune hepatitis: correlation with clinical staging. Radiology 2005 0.78
88 MR imaging findings of small bowel hemorrhage: two cases of mural involvement and one of perimural. J Magn Reson Imaging 2009 0.77
89 MR imaging of the pediatric liver. Magn Reson Imaging Clin N Am 2002 0.77
90 Debris-filled biliary system: a difficult diagnosis on MRI and MRCP. Clin Imaging 2012 0.77
91 Focal liver lesions evaluated by MR imaging. Diagn Interv Radiol 2006 0.77
92 Epithelioid hemangioendothelioma of the liver. MR imaging findings. Magn Reson Imaging 2002 0.77
93 Liver metastases from unknown primary site: demonstration on MR images. Magn Reson Imaging 2003 0.77
94 Future directions in body magnetic resonance imaging. Top Magn Reson Imaging 2005 0.77
95 Angiogenesis in hepatocellular nodules: correlation of MR imaging and vascular endothelial growth factor. J Magn Reson Imaging 2004 0.77
96 MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 2003 0.77
97 Efficacy and tolerability of laparoscopic-assisted radiofrequency ablation of hepatocellular carcinoma in patients above 60 years of age. Surg Laparosc Endosc Percutan Tech 2010 0.77
98 Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol 2008 0.77
99 Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings. Magn Reson Imaging 2004 0.77
100 Magnetic resonance imaging and expression of vascular endothelial growth factor in hepatocellular nodules in cirrhosis and hepatocellular carcinomas. Top Magn Reson Imaging 2005 0.77
101 Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI? Abdom Imaging 2014 0.77
102 Gadolinium Deposition in Humans: When Did We Learn That Gadolinium Was Deposited In Vivo? Invest Radiol 2016 0.77
103 Hepatic sarcoidosis: MR appearances in patients with chronic liver disease. Magn Reson Imaging 2012 0.76
104 Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients? AJR Am J Roentgenol 2004 0.76
105 Magnetic resonance imaging of small bowel Crohn's disease. Acta Med Port 2012 0.76
106 Perilesional enhancement of liver cavernous hemangiomas in magnetic resonance imaging. Abdom Imaging 2014 0.76
107 Post-contrast T1-weighted sequences in pediatric abdominal imaging: comparative analysis of three different sequences and imaging approach. Pediatr Radiol 2014 0.76
108 MRI of pregnant patients for suspected pulmonary embolism: steady-state free precession vs postgadolinium 3D-GRE. Acta Med Port 2013 0.76
109 Magnetic resonance evaluation of pregnant patients with acute abdominal pain. Semin Ultrasound CT MR 2005 0.75
110 Can the relation between gadopentetate dimeglumine and FDG uptake in colorectal liver metastases be used clinically? Radiology 2005 0.75
111 Hepatocellular carcinoma missed on gadolinium enhanced MR imaging, discovered in liver explants: retrospective evaluation. J Magn Reson Imaging 2006 0.75
112 Health care reform in the USA: Recommendations from USA and non-USA radiologists. World J Radiol 2012 0.75
113 Focal fat masquerading as malignancy in the liver graft of a post-transplant patient. Dig Dis Sci 2011 0.75
114 MRI findings of gastric metastases from breast carcinoma. Magn Reson Imaging 2005 0.75
115 Liver adenomatosis: serial investigation on MRI. Abdom Imaging 2014 0.75
116 Inter- and intra-individual comparative study of two gadolinium-based agents: A pilot study. Abdom Imaging 2015 0.75
117 Magnetic resonance imaging features of focal liver lesions after intervention. Top Magn Reson Imaging 2005 0.75
118 Assessment of aorto-iliac disease with magnetic resonance angiography using arterial phase 3-D gradient-echo and interstitial phase 2-D fat-suppressed spoiled gradient-echo sequences. J Magn Reson Imaging 2003 0.75
119 Renal cell carcinoma in a transplanted kidney: MR imaging findings. Magn Reson Imaging 2003 0.75
120 Overlap syndrome of autoimmune chronic liver diseases: MRI findings. J Magn Reson Imaging 2010 0.75
121 Primary peritoneal carcinoma: computed tomography and magnetic resonance findings. J Comput Assist Tomogr 2008 0.75
122 Renal malacoplakia: demonstration by MR imaging. Magn Reson Imaging 2002 0.75
123 Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging. Radiology 2013 0.75
124 Enhancement of liver and pancreas on late hepatic arterial phase imaging: quantitative comparison among multiple gadolinium-based contrast agents at 1.5 Tesla MRI. J Magn Reson Imaging 2013 0.75
125 Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease. Magn Reson Imaging 2005 0.75
126 MR-PET co-registration in upper abdominal imaging: quantitative comparison of two different T1-weighted gradient echo sequences: initial observations. Abdom Imaging 2015 0.75
127 Feasibility of post-gadolinium three-dimensional gradient-echo sequence to evaluate the pulmonary arterial vasculature. Magn Reson Imaging 2009 0.75
128 Post-treatment malignant liver lesions. MR imaging. Magn Reson Imaging Clin N Am 2002 0.75
129 Magnetic resonance imaging of the liver: a review. Expert Opin Med Diagn 2007 0.75
130 Case report of systemic IgG-related disease affecting the pancreas and orbit. Clin Imaging 2012 0.75
131 Future directions in MR imaging of the female pelvis. Magn Reson Imaging Clin N Am 2006 0.75
132 Incidence of pulmonary embolism and other chest findings in younger patients using multidetector computed tomography. Acta Radiol 2010 0.75
133 Pancreatic cancer: correlation of MR findings, clinical features, and tumor grade. J Magn Reson Imaging 2007 0.75
134 An overview of imaging techniques for liver metastases management. Expert Rev Gastroenterol Hepatol 2015 0.75
135 MR imaging evaluation of the adnexa. Magn Reson Imaging Clin N Am 2006 0.75
136 MR enterography: relationship between intestinal fold pattern and the clinical presentation of adult celiac disease. J Magn Reson Imaging 2012 0.75
137 Comparison of the incidence of pancreatic abnormalities between high risk and control patients: prospective pilot study with 3 Tesla MR imaging. J Magn Reson Imaging 2011 0.75
138 Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance. J Magn Reson Imaging 2004 0.75
139 Prospective comparison of high- and low-spatial-resolution dynamic MR imaging with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinoma. Eur Radiol 2008 0.75
140 Immunoblastic large B-cell lymphoma of the peripancreatic head region: MR findings. Magn Reson Imaging 2004 0.75
141 Bone metastases: evaluation of acuity of lesions using dynamic gadolinium-chelate enhancement, preliminary results. J Magn Reson Imaging 2011 0.75
142 MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations. Abdom Imaging 2015 0.75